Potential Long-Term Risks Although AOD-9604 does not increase IGF-1 levels, there are concerns about its long-term metabolic effects, including: Unknown impact on fat metabolism regulation Since AOD-9604 alters fat-burning pathways, researchers are still investigating whether prolonged use could affect natural fat metabolism
Half the stack (tirzepatide) is an FDA-approved drug
By ensuring deep sleep and supporting biochemical processes, this peptide helps the body neutralize harmful factors more effectively, which translates into better skin and hair condition and overall vitality
Most mild reactions, including redness, warmth, and minor itching, resolve within 24 to 48 hours
Es werden zwei Standard-Rahmenbreiten angeboten: die schmale Variante mit ca